Coumadin, Warfarin Polymorphism
Order Name
COUM POLYM
Test Number: 5524120
Revision Date 08/24/2009
Test Number: 5524120
Revision Date 08/24/2009
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
CYP2C9*2 Coumadin Polymorphism
|
Signal Amplification, Invader chemistry detection | |
|
CYP2C9*3 Coumadin Polymorphism
|
Signal Amplification, Invader chemistry detection | |
|
VKORC1 Coumadin Polymorphism
|
Signal Amplification, Invader chemistry detection |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 5 mL (3) | EDTA Whole Blood | EDTA (Lavender Top) | Room Temperature |
| Instructions | Keep specimen as whole blood at room temperature. Do not centrifuge, do not refrigerate. Specimen cannot be shared with other testing for risk of DNA contamination. | |||
| GENERAL INFORMATION | |
|---|---|
| Testing Schedule | Volume Dependant |
| Expected TAT | 1-3 Days |
| Clinical Use | Identification of patient CYP2C9*2, CYP2C9*3, VKORC1 polymorphisms can help predict expected drug metabolism enzyme activity allowing clinicians to individualize drug treatment for each patient. Individualized therapy may assist patients by reducing adverse drug reactions and optimizing drug dose requirements. |
| CPT Code(s) | 83891; 83900; 83901; 83892X6; 83896X9; 83903X3; 83908X3; 83912 |
| Lab Section | Hematology |